Dr. Idowu earned her medical degree and completed her residency in internal medicine at Texas Tech University Health Sciences Center in Lubbock. She held a fellowship in hematology at the University of Florida. Dr. Idowu presently serves as professor and director of the hematology division and associate program director of the McGovern Medical School Hematology/Oncology Fellowship at UTHealth Houston. She is also the director of UT Physicians’ Comprehensive Adult Sickle Cell Center. Her clinical interest is in treating patients with hemoglobinopathies, anemias, thrombocytopenia, myeloproliferative neoplasm, thrombotic disorders, and rare blood disorders. Dr. Idowu has been awarded the Dean’s Teaching Excellence Award on a yearly basis from 2011 to 2024. She is a recipient of the John P. and Katherine G. McGovern Master Teacher Award and the Esteemed Educator Award in 2025. She is the Co-chair for Sickle Cell Task Force MHMD Clinical Programs Committee (CPC) for Memorial Hermann Physician Network, Houston, Texas, since 2023. This Task Force won a system-wide Impact award for the Fiscal year 2025.
In addition to serving as principal investigator for more than 15 clinical trials, Dr. Idowu is a reviewer for multiple journals, including Blood Advances and Journal of Investigative Medicine. She has had more than 30 articles and 70 research abstracts published in peer-reviewed journals. Dr. Idowu serves as a PI and council member of the American Society of Hematology Clinical Trial Network (ASH CTN) and the Research Collaborative for SCD. Dr. Idowu’s philosophy is to offer excellent care and to treat everyone with utmost respect.
Benign and malignant hematology disorders including anemias, Thrombocytopenias, Leukopenias, thrombosis, hypercoagulable disorders, coagulopathy, hemoglobinopathies, myeloproliferative disorders, MDS, chronic leukemias and lymphomas, and plasma cell dyscrasias.